ADP Consultancy

By using this website I agree that I am an Eye Care/Health Care Professional and have read, understood and accepted all the terms of use as outlined in the Disclaimer & the Privacy Policy

Close this notice

Full Data Page (Products) List

Notes

Details

How Supplied
"A clear, colourless solution Free from visible particulate matter" (13.5ml) in plastic bottle.
Dosing
ECP/HCP to advise. "Adults and Children : One or two drops into each eye up to four times a day or as indicated by the doctor. Elderly: There is no current evidence for alteration of the dose. Route of administration: Topical ophthalmic." Always read SmPC via link in Notes below.
Formulation
Sterile Aqueous Solution containing:, Active substance: 20 mg Sodium Cromoglicate (2% w/v), Excipient(s) with known effect - Benzalkonium chloride 0.10 mg/ml, Disodium edetate, Sodium chloride, Polysorbate 80, Water for injection. Always read SmPC via link in Notes below.
Contact Lens Use
No, see Contra-Indications/Cautions
Indications
The prevention and treatment of acute, seasonal and perennial allergic conjunctivitis. Always read SmPC via link in Notes below.
Contra-Indications/Cautions
See Notes 6 & 7. Due to the potentially wide range and seriousness of the Contra-indications/Cautions relating to this product the prescriber of this medicine should fully aware of original documentation, SmPC, Patient Information Leaflet etc. All pts should be instructed to read the Patient Information Leaflet before using product. Attention is drawn to this products P classification. "This formulation of Sodium Cromoglicate Eye Drops contains 0.1mg/ml (4.5 micrograms per dose) benzalkonium chloride as a preservative which may be deposited in soft contact lenses. Hence, Sodium Cromoglicate Eye Drops should not be used while wearing these lenses. The lenses should be removed before instillation of the drops and not reinserted earlier than 15 minutes after use. Benzalkonium chloride has been reported to cause eye irritation, symptoms of dry eyes and may affect the tear film and corneal surface. Should be used with caution in dry eye patients and in patients where the cornea may be compromised. Patients should be monitored in case of prolonged use". Discard 28 days after first opening. If symptoms become worse - pt to seek medical advice immediately. Pregnancy/lactation - see SmPC. Advise pt to read and understand all accompanying product information before first use - EDDB. Always read SmPC via link in Notes below.
Adverse Reactions
Due to the potentially wide range and seriousness of the Adverse Reactions relating to this product the prescriber of this medicine should fully aware of original documentation, including SmPC and PIL - see Notes. All pts should be instructed to read the Patient Information Leaflet before using product. If irritation occurs, persists or increases, pt to discontinue use and consult ECP/HCP - EDDB. If vision changes or irritation occurs, persists or increases, pt to discontinue use and consult ECP/HCP. Always read SmPC via link in Notes below.
Legal Category
POM.
Notes

1. SmPC: https://www.medicines.org.uk/emc/product/418/smpc

2. PIL: https://www.medicines.org.uk/emc/product/418/pil

3. ON NO ACCOUNT SHOULD THE DATA CONTAINED ON THIS PAGE BE USED AS A BASIS FOR CLINICAL DECISION MAKING/PX ADVICE  - THIS SHOULD ONLY BE DONE BY REFERENCE TO THE ORIGINAL PRESCRIBER AND/OR PRODUCT DOCUMENTATION.

4. Because products are regularly improved and change, product data and advice may occasionally change. As a result, EDDB recommends that you and your patient always read the product label and Patient Information Leaflet carefully before using any products. Please do not solely rely on the information provided on this website. Because of this, EDDB is unable to accept liability for any inaccuracies or incorrect information contained on this site.

5. Pt MUST BE INSTRUCTED TO READ ACCOMPANYING PATIENT INFORMATION LEAFLET BEFORE USE.

6. Attention is drawn to this product's POM/P category and the full relevant legal restrictions therof.

7. Attention is drawn to specific warnings in Contra-Indications/Cautions and Adverse Reactions on this page and the full text of the SPC and PIL, all of which should be read and understood by the prescriber.

8.REMINDER: TERMS OF USE. By using this website I agree I am an Eye Care/Health Care Professional and have read, understood and accepted all the terms of use as outlined in the Disclaimer and the Privacy Policy.

Product information

Not every product may be listed, or have full data. Every effort is being made to fill in the gaps as soon as possible. It will continue to grow in breadth and depth as data arrives and products are released, almost on a daily basis. Endeavours will be made to include information on 'retailers' drops such as Sainsbury's, Superdrug etc, so you can have data available when your patient tells you they are using Tesco Allergy Drops (Sodium Cromoglicate) and asks "can I use it with my contact lenses?". If you would like to propose products for the database, have any ideas, suggestions, would like to provide missing data or see any factual inaccuracies please email adpconsultancy@gmail.com